Innocan, Pharma

Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Innocan Pharma Corporation Canada Alberta Israel

en | boerse | 67932456 |